Stein J P, Grossfeld G D, Freeman J A, Esrig D, Ginsberg D A, Cote R J, Skinner E C, Boyd S D, Lieskovsky G, Skinner D G
Department of Urology, University of Southern California, Los Angeles, USA.
J Urol. 1997 Aug;158(2):400-5.
Orthotopic lower urinary tract reconstruction has revolutionized urinary diversion following cystectomy. Initially performed solely in male patients, orthotopic diversion has now become a viable option in women. Currently, the orthotopic neobladder is the diversion of choice for women requiring lower urinary tract reconstruction at our institution. We evaluate and update our clinical and functional experience with orthotopic reconstruction in female patients.
Since June 1990, 34 women 31 to 86 years old (median age 67) have undergone orthotopic lower urinary tract reconstruction following cystectomy. Indications for cystectomy included transitional cell carcinoma in 29 patients, urachal adenocarcinoma in 1, mesenchymal tumor of endometrial origin in 1, cervical carcinoma in 1 and a fibrotic radiated bladder in 1. In addition, 1 woman underwent undiversion to the native urethra following a previous simple cystectomy and cutaneous diversion for eosinophilic cystitis. Data were analyzed according to postoperative early and late complications, survival, tumor recurrence, pathological evaluation of the cystectomy specimen, continence status, voiding pattern and patient satisfaction. The median followup in this group of patients was 30 months (range 17 to 70).
There were no perioperative deaths, and 4 early (11%) and 3 (9%) late complications. Four patients died, none with a urethral recurrence, including 3 of metastatic bladder cancer and 1 of unrelated causes. In another patient with an extensive mesenchymal tumor of the uterus a sigmoid tumor recurred requiring conversion of the orthotopic reservoir to a cutaneous diversion. All of the remaining 29 patients are alive without evidence of disease. Intraoperative frozen section of the distal surgical margin (proximal urethra) accurately evaluated (confirmed by permanent section) the proximal urethra prospectively for tumor in all 29 specimens removed for transitional cell carcinoma, including 28 specimens (97%) without evidence of tumor and 1 specimen with carcinoma in situ. Complete daytime and nighttime continence was reported by 29 (88%) and 27 (82%) of 33 evaluable patients, respectively. A total of 28 patients (85%) void to completion, while 5 (15%) require some form of intermittent catheterization to empty the neobladder. Patient satisfaction is overwhelming.
The excellent clinical and functional results demonstrated with further followup confirm our initial experience with orthotopic diversion in women. Careful selection of appropriate female candidates for orthotopic diversion is critical, and includes preoperative evaluation of the bladder neck and intraoperative frozen section analysis of the distal cystectomy margin. Furthermore, close monitoring of the retained urethra is mandatory in all women undergoing orthotopic diversion. We believe that the orthotopic neobladder is the urinary diversion of choice in women following cystectomy.
原位下尿路重建彻底改变了膀胱切除术后的尿流改道方式。原位改道最初仅在男性患者中进行,如今在女性患者中也已成为一种可行的选择。目前,原位新膀胱是我院需要进行下尿路重建的女性患者的首选改道方式。我们评估并更新了女性患者原位重建的临床和功能经验。
自1990年6月以来,34名年龄在31至86岁(中位年龄67岁)的女性在膀胱切除术后接受了原位下尿路重建。膀胱切除的指征包括29例移行细胞癌、1例脐尿管腺癌、1例子宫内膜来源的间叶肿瘤、1例宫颈癌和1例放射性纤维化膀胱。此外,1名女性在先前因嗜酸性膀胱炎进行简单膀胱切除术和皮肤造口术后,又进行了恢复至原尿道的改道。根据术后早期和晚期并发症、生存率、肿瘤复发、膀胱切除标本的病理评估、控尿状态、排尿模式及患者满意度对数据进行分析。这组患者的中位随访时间为30个月(范围17至70个月)。
无围手术期死亡病例,有4例早期(11%)和3例(9%)晚期并发症。4例患者死亡,均无尿道复发,其中3例死于转移性膀胱癌,1例死于无关原因。另1例患有广泛子宫间叶肿瘤的患者,乙状结肠肿瘤复发,需要将原位贮尿囊改为皮肤造口。其余29例患者均存活,无疾病证据。在所有29例因移行细胞癌切除的标本中,术中对远端手术切缘(近端尿道)进行的冷冻切片准确地(经永久切片证实)前瞻性评估了近端尿道有无肿瘤,其中28例标本(97%)无肿瘤证据,1例标本有原位癌。33例可评估患者中,分别有29例(88%)和27例(82%)报告白天和夜间完全控尿。共有28例患者(85%)能自主排尿至膀胱排空,而5例(15%)需要某种形式的间歇性导尿来排空新膀胱。患者满意度极高。
进一步随访所显示的出色临床和功能结果证实了我们在女性原位改道方面的初步经验。仔细挑选合适的女性原位改道候选者至关重要,包括术前对膀胱颈的评估以及术中对膀胱切除远端切缘的冷冻切片分析。此外,对所有接受原位改道的女性患者,必须密切监测保留的尿道。我们认为,原位新膀胱是女性膀胱切除术后尿流改道的首选方式。